Breast Cancer Mammography Screening Market Size, Trends and Insights By Type (Screening Mammography, Diagnostic Mammography), By Technology (Analog Mammography, Digital Mammography, 3D Mammography, Others), By Product (Film-Screen Mammography, Full-Field Digital Mammography (FFDM), 3D Breast Tomosynthesis, Cone Beam Breast CT (CBCT), Others), By End User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Report Snapshot
| Study Period: | 2024-2033 |
| Fastest Growing Market: | Asia-Pacific |
| Largest Market: | Europe |
Major Players
- Hologic Inc.
- Siemens Healthineers AG
- General Electric Company
- Fujifilm Holdings Corporation
- Koninklijke Philips N.V.
- Others
Reports Description
As per the current market research conducted by CMI Team, the global Breast Cancer Mammography Screening Market is expected to record a CAGR of 8.6% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 4.1 Billion. By 2033, the valuation is anticipated to reach USD 8.7 Billion.
Global Breast Cancer Incidence in Women in 2020 (ASR/100,000)
| Country | ASR/100,000 | Number |
| Belgium | 113.2 | 11,734 |
| The Netherlands | 100.9 | 15,725 |
| Luxembourg | 99.8 | 497 |
| France | 99.1 | 58,083 |
| France, New Caledonia | 99 | 185 |
| Denmark | 98.4 | 5,083 |
| Australia | 96 | 19,617 |
| New Zealand | 93 | 3,660 |
| Finland | 92.4 | 5,228 |
| US | 90.3 | 2,53,465 |
Source: According to the World Cancer Research Fund International
The Breast Cancer Mammography Screening Market involves the global provision of diagnostic services for breast cancer detection. This market encompasses various technologies, including digital mammography, 3D tomosynthesis, and advanced imaging solutions. Key players, such as Hologic, Siemens Healthineers, and Philips Healthcare, drive advancements to enhance screening accuracy.
The market is influenced by rising breast cancer incidence, technological innovations, and a growing emphasis on early detection. Ongoing initiatives include public awareness campaigns and collaborations, ensuring improved accessibility to screening services. The evolving landscape aims to mitigate breast cancer’s impact through timely diagnosis and intervention, fostering better patient outcomes.
Breast Cancer Mammography Screening Market – Significant Growth Factors
The Breast Cancer Mammography Screening Market presents significant growth opportunities due to several factors:
- Technological Advancements: Continuous technological innovations, such as 3D tomosynthesis and artificial intelligence integration, drive the market. Advanced imaging solutions enhance diagnostic accuracy, contributing to improved early detection and treatment outcomes.
- Increasing Breast Cancer Incidence: The rising prevalence of breast cancer globally remains a significant driver. A higher incidence prompts a greater demand for mammography screenings, positioning early detection as a crucial factor in mitigating the impact of the disease.
- Government Initiatives and Awareness Campaigns: Supportive government initiatives, coupled with extensive awareness campaigns, significantly drive market dynamics. Public health programs and campaigns play a vital role in encouraging routine screenings, fostering early detection, and improving overall breast health.
- Growing Healthcare Infrastructure: Advancements in healthcare infrastructure globally contribute to increased accessibility to mammography screening services. The expansion of healthcare facilities and breast cancer screening programs, particularly in developing regions, positively impacts market growth.
- Personalized Screening Protocols: The opportunity lies in developing and implementing personalized screening protocols. Tailoring mammography approaches based on individual risk factors and patient history can enhance the effectiveness of early detection strategies and improve overall patient outcomes.
Breast Cancer Mammography Screening Market – Mergers and Acquisitions
The Breast Cancer Mammography Screening Market has seen several mergers and acquisitions in recent years, with companies seeking to expand their market presence and leverage synergies to improve their product offerings and profitability. Some notable examples of mergers and acquisitions in the Breast Cancer Mammography Screening Market include:
- In 2022, Volpara Health unveiled enhanced products at the SBI/ACR Breast Imaging Symposium 2022, strengthening its integrated platform for personalized breast care. The AI-driven breast software tools by Volpara deliver top-tier mammography quality, comprehensive reporting, volumetric breast density measurements, and precise cancer risk assessments, contributing to advanced and personalized breast health solutions.
- In 2022, Roche introduced the AVENIO Edge System, a cutting-edge sequencing platform designed to enhance precision medicine solutions. With its fully automated and integrated capabilities, the system aims to advance sequencing technologies and optimize the delivery of personalized cancer treatments.
These mergers and acquisitions have helped companies expand their product offerings, improve their market presence, and capitalize on growth opportunities in the Breast Cancer Mammography Screening Market. The trend is expected to continue as companies seek to gain a competitive edge in the market.
COMPARATIVE ANALYSIS OF THE RELATED MARKET
| Breast Cancer Mammography Screening Market | Cell Therapy Technologies Market | Womens Health Diagnostics Market |
| CAGR 8.6% (Approx) | CAGR 14% (Approx) | CAGR 7.6% (Approx) |
| USD 8.7 Billion by 2033 | USD 8.5 Billion by 2032 | USD 45.4 Billion by 2032 |
Breast Cancer Mammography Screening Market – Significant Threats
The Breast Cancer Mammography Screening Market faces several significant threats that could impact its growth and profitability in the future. Some of these threats include:
- Pandemic-Related Disruptions: Pandemic-induced disruptions pose a significant threat to the breast cancer mammography screening market. Lockdowns, fear of exposure, and reallocation of resources during health crises can lead to a decline in routine screenings, potentially resulting in delayed diagnoses.
- Regulatory Challenges: Stringent regulatory requirements and compliance issues pose a threat. Changes in regulatory landscapes or difficulties in meeting evolving standards can impact market entry, product approvals, and overall operational efficiency.
- Technological Barriers: Rapid technological advancements can create challenges for certain healthcare providers or regions with limited access to updated screening technologies. This technological lag may result in disparities in screening capabilities and hinder uniform progress in breast cancer detection.
- Public Perception and Awareness: Misinformation or lack of awareness about the importance of mammography screenings may pose a threat. Public scepticism or misconceptions can lead to decreased screening rates, hindering the market’s ability to fulfill its early detection objectives.
- Economic Factors: Economic downturns or financial constraints can impact healthcare spending, potentially leading to reduced investments in breast cancer screening programs. Economic challenges may limit the accessibility of mammography services, particularly in lower-income populations, exacerbating disparities in breast cancer detection and care.
Category-Wise Insights
By Type:
- Screening Mammography: Screening mammography involves routine examinations in asymptomatic individuals to detect breast cancer at an early, more treatable stage. Trends include advancements in digital technology, AI integration for improved accuracy, and a focus on reducing radiation exposure, ensuring efficient and patient-friendly screening experiences.
- Diagnostic Mammography: Diagnostic mammography is used in individuals with breast symptoms or abnormalities to provide detailed imaging for diagnosis. Trends encompass enhanced imaging resolution, utilization of 3D tomosynthesis for comprehensive evaluation, and the integration of advanced technologies for precise diagnostic insights, optimizing patient care.
By Technology
- Analog Mammography: Analog mammography, the traditional method utilizing film-based X-ray imaging, is witnessing a declining trend. Healthcare providers are gradually phasing out analog systems due to their lower sensitivity and limited diagnostic capabilities. Digital alternatives offer superior image quality, ease of storage, and manipulation, making them the preferred choice for modern breast cancer mammography screenings.
- Digital Mammography: Digital mammography, a contemporary approach using electronic receptors for image capture, dominates the market with an increasing trend. The transition from analog to digital technology is driven by the improved image quality, efficient data management, and enhanced diagnostic capabilities. Ongoing advancements in digital mammography contribute to its growing adoption, ensuring a higher standard in breast cancer screening.
- 3D Mammography (Tomosynthesis): 3D mammography, or tomosynthesis, represents a transformative trend in breast cancer screening. By capturing multiple images from varied angles, it reconstructs a three-dimensional view of the breast, reducing false positives and enhancing cancer detection rates. The trend leans towards widespread adoption as continual advancements in 3D mammography technology promise increased accuracy and reliability.
- Others: Innovative technologies like contrast-enhanced mammography and breast ultrasound form the frontier of breast cancer mammography screening. The trend involves exploring these emerging technologies to improve sensitivity and specificity in breast cancer detection. Continuous research and development efforts focus on innovative approaches within this category, promising advancements that contribute to enhanced screening accuracy and a more patient-centric experience.
By Product
- Film-Screen Mammography: Film-screen mammography, the traditional approach, involves X-ray film and a cassette to capture breast images. Trends show a decline due to digital advancements, but in resource-limited settings, it remains cost-effective for routine screenings.
- Full-Field Digital Mammography (FFDM): FFDM employs digital receptors for image capture. Trends reveal widespread adoption due to superior image quality, quicker results, and ease of storage. Its efficiency contributes to enhanced diagnostic accuracy and improved patient outcomes.
- 3D Breast Tomosynthesis: 3D tomosynthesis captures multiple images from varying angles, offering a 3D view. Trends showcase its growing prominence for superior lesion detection, reduced false positives, and enhanced diagnostic accuracy, particularly in dense breast tissues.
- Cone Beam Breast CT (CBCT): CBCT utilizes cone-shaped X-ray beams for detailed 3D breast imaging. Trends indicate its potential for improved visualization, especially in complex cases. However, challenges such as radiation exposure limit its widespread adoption, leading to ongoing research.
- Others: This category encompasses emerging technologies like molecular breast imaging and contrast-enhanced mammography. Trends vary, with ongoing exploration of novel techniques, such as AI integration and advanced biopsy technologies, to further refine breast cancer screening capabilities.
By End Users
- Hospitals: Hospitals serve as primary hubs for breast cancer mammography screenings, offering comprehensive diagnostic services. Trends include the integration of advanced technologies like 3D tomosynthesis, creating of one-stop breast health centers within hospitals, and collaborative efforts with radiologists for efficient screening.
- Diagnostic Centers: Dedicated diagnostic centers specialize in breast cancer mammography screenings, providing focused and streamlined services. Trends involve state-of-the-art digital mammography equipment, personalized screening protocols, and emphasis on patient comfort, ensuring accurate and timely breast cancer detection.
- Ambulatory Surgical Centers: Ambulatory Surgical Centers (ASCs) increasingly offer breast cancer mammography screenings as part of outpatient services. Trends include the adoption of portable mammography units for convenience, shorter waiting times, and streamlined processes, making breast cancer screenings more accessible within ambulatory settings.
- Others: Other end-user segments encompass diverse settings like women’s health clinics and mobile screening units. Trends include innovative outreach programs, community-based initiatives, and collaborations with non-profit organizations to extend breast cancer mammography screenings to underserved populations, ensuring broader access to preventive healthcare.
Report Scope
| Feature of the Report | Details |
| Market Size in 2024 | USD 4.1 Billion |
| Projected Market Size in 2033 | USD 8.7 Billion |
| Market Size in 2023 | USD 3.8 Billion |
| CAGR Growth Rate | 8.6% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Type, Technology, Product, End User and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Breast Cancer Mammography Screening Market – Regional Analysis
The Breast Cancer Mammography Screening Market is segmented into various regions, including North America, Europe, Asia-Pacific, and LAMEA. Here is a brief overview of each region:
- North America: In North America, trends in the Breast Cancer Mammography Screening Market include a focus on precision medicine with genetic screening integration, widespread adoption of 3D tomosynthesis for improved diagnostic accuracy, and an emphasis on digital health technologies for seamless patient engagement and data integration.
- Europe: European trends revolve around cross-border collaborations for data sharing and research, increasing adoption of AI-driven diagnostic tools to enhance efficiency, and the integration of breast cancer screening into comprehensive women’s health programs, emphasizing preventive care and early detection.
- Asia-Pacific: In the Asia-Pacific region, trends encompass the implementation of mobile mammography units for rural outreach, growing awareness through targeted educational campaigns, and the adoption of cost-effective digital mammography solutions. Additionally, increased research on population-specific risk factors contributes to tailored screening approaches.
- LAMEA (Latin America, Middle East, and Africa): LAMEA trends involve the expansion of breast cancer screening programs in urban and rural areas, leveraging telehealth for remote consultations, and the integration of mobile health clinics. Initiatives focus on overcoming infrastructure challenges, improving accessibility, and addressing cultural nuances to promote regular screenings.
Competitive Landscape – Breast Cancer Mammography Screening Market
The Breast Cancer Mammography Screening Market is highly competitive, with a large number of manufacturers and retailers operating globally. Some of the key players in the market include:
- Hologic Inc.
- Siemens Healthineers AG
- General Electric Company
- Fujifilm Holdings Corporation
- Koninklijke Philips N.V.
- Canon Inc.
- Planmed Oy
- Carestream Health Inc.
- Hitachi Ltd.
- Agfa-Gevaert Group
- Dilon Technologies Inc.
- Internazionale Medico Scientifica S.r.l.
- Metaltronica S.p.A.
- FUJIFILM Sonosite Inc.
- Delphinus Medical Technologies Inc.
- Others
These companies operate in the market through various strategies such as product innovation, mergers and acquisitions, and partnerships.
Emerging players like Ezra AI and Mammoth Diagnostics are pioneering innovation in breast cancer mammography screening. Ezra AI focuses on AI-driven early detection, while Mammoth Diagnostics explores novel genetic screening methods. These entrants leverage technology to enhance accuracy and accessibility, disrupting traditional approaches.
Established leaders such as Hologic, Siemens Healthineers, and Philips Healthcare dominate with extensive portfolios and global influence. They maintain market dominance through continuous technological advancements, strategic collaborations, and comprehensive healthcare solutions, ensuring a stronghold on breast cancer mammography screening’s evolving landscape.
The Breast Cancer Mammography Screening Market is segmented as follows:
By Type
- Screening Mammography
- Diagnostic Mammography
By Technology
- Analog Mammography
- Digital Mammography
- 3D Mammography
- Others
By Product
- Film-Screen Mammography
- Full-Field Digital Mammography (FFDM)
- 3D Breast Tomosynthesis
- Cone Beam Breast CT (CBCT)
- Others
By End User
- Hospitals
- Diagnostic Centers
- Ambulatory Surgical Centers
- Others
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market Research Methodology
- Chapter 2. Executive Summary
- 2.1 Global Breast Cancer Mammography Screening Market, (2024 – 2033) (USD Billion)
- 2.2 Global Breast Cancer Mammography Screening Market: snapshot
- Chapter 3. Global Breast Cancer Mammography Screening Market – Industry Analysis
- 3.1 Breast Cancer Mammography Screening Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Technological Advancements
- 3.2.2 Increasing Breast Cancer Incidence
- 3.2.3 Government Initiatives and Awareness Campaigns
- 3.2.4 Growing Healthcare Infrastructure
- 3.2.5 Personalized Screening Protocols.
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Product
- 3.7.4 Market Attractiveness Analysis By End User
- Chapter 4. Global Breast Cancer Mammography Screening Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Breast Cancer Mammography Screening Market: Company Market Share, 2024
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Breast Cancer Mammography Screening Market – Type Analysis
- 5.1 Global Breast Cancer Mammography Screening Market Overview: By Type
- 5.1.1 Global Breast Cancer Mammography Screening Market Share, By Type, 2024 and – 2033
- 5.2 Screening Mammography
- 5.2.1 Global Breast Cancer Mammography Screening Market by Screening Mammography, 2024 – 2033 (USD Billion)
- 5.3 Diagnostic Mammography
- 5.3.1 Global Breast Cancer Mammography Screening Market by Diagnostic Mammography, 2024 – 2033 (USD Billion)
- 5.1 Global Breast Cancer Mammography Screening Market Overview: By Type
- Chapter 6. Global Breast Cancer Mammography Screening Market – Technology Analysis
- 6.1 Global Breast Cancer Mammography Screening Market Overview: By Technology
- 6.1.1 Global Breast Cancer Mammography Screening Market Share, By Technology, 2024 and – 2033
- 6.2 Analog Mammography
- 6.2.1 Global Breast Cancer Mammography Screening Market by Analog Mammography, 2024 – 2033 (USD Billion)
- 6.3 Digital Mammography
- 6.3.1 Global Breast Cancer Mammography Screening Market by Digital Mammography, 2024 – 2033 (USD Billion)
- 6.4 3D Mammography
- 6.4.1 Global Breast Cancer Mammography Screening Market by 3D Mammography, 2024 – 2033 (USD Billion)
- 6.5 Others
- 6.5.1 Global Breast Cancer Mammography Screening Market by Others, 2024 – 2033 (USD Billion)
- 6.1 Global Breast Cancer Mammography Screening Market Overview: By Technology
- Chapter 7. Global Breast Cancer Mammography Screening Market – Product Analysis
- 7.1 Global Breast Cancer Mammography Screening Market Overview: By Product
- 7.1.1 Global Breast Cancer Mammography Screening Market Share, By Product, 2024 and – 2033
- 7.2 Film-Screen Mammography
- 7.2.1 Global Breast Cancer Mammography Screening Market by Film-Screen Mammography, 2024 – 2033 (USD Billion)
- 7.3 Full-Field Digital Mammography (FFDM)
- 7.3.1 Global Breast Cancer Mammography Screening Market by Full-Field Digital Mammography (FFDM), 2024 – 2033 (USD Billion)
- 7.4 3D Breast Tomosynthesis
- 7.4.1 Global Breast Cancer Mammography Screening Market by 3D Breast Tomosynthesis, 2024 – 2033 (USD Billion)
- 7.5 Cone Beam Breast CT (CBCT)
- 7.5.1 Global Breast Cancer Mammography Screening Market by Cone Beam Breast CT (CBCT), 2024 – 2033 (USD Billion)
- 7.6 Others
- 7.6.1 Global Breast Cancer Mammography Screening Market by Others, 2024 – 2033 (USD Billion)
- 7.1 Global Breast Cancer Mammography Screening Market Overview: By Product
- Chapter 8. Global Breast Cancer Mammography Screening Market – End User Analysis
- 8.1 Global Breast Cancer Mammography Screening Market Overview: By End User
- 8.1.1 Global Breast Cancer Mammography Screening Market Share, By End User, 2024 and – 2033
- 8.2 Hospitals
- 8.2.1 Global Breast Cancer Mammography Screening Market by Hospitals, 2024 – 2033 (USD Billion)
- 8.3 Diagnostic Centers
- 8.3.1 Global Breast Cancer Mammography Screening Market by Diagnostic Centers, 2024 – 2033 (USD Billion)
- 8.4 Ambulatory Surgical Centers
- 8.4.1 Global Breast Cancer Mammography Screening Market by Ambulatory Surgical Centers, 2024 – 2033 (USD Billion)
- 8.5 Others
- 8.5.1 Global Breast Cancer Mammography Screening Market by Others, 2024 – 2033 (USD Billion)
- 8.1 Global Breast Cancer Mammography Screening Market Overview: By End User
- Chapter 9. Breast Cancer Mammography Screening Market – Regional Analysis
- 9.1 Global Breast Cancer Mammography Screening Market Regional Overview
- 9.2 Global Breast Cancer Mammography Screening Market Share, by Region, 2024 & – 2033 (USD Billion)
- 9.3. North America
- 9.3.1 North America Breast Cancer Mammography Screening Market, 2024 – 2033 (USD Billion)
- 9.3.1.1 North America Breast Cancer Mammography Screening Market, by Country, 2024 – 2033 (USD Billion)
- 9.3.1 North America Breast Cancer Mammography Screening Market, 2024 – 2033 (USD Billion)
- 9.4 North America Breast Cancer Mammography Screening Market, by Type, 2024 – 2033
- 9.4.1 North America Breast Cancer Mammography Screening Market, by Type, 2024 – 2033 (USD Billion)
- 9.5 North America Breast Cancer Mammography Screening Market, by Technology, 2024 – 2033
- 9.5.1 North America Breast Cancer Mammography Screening Market, by Technology, 2024 – 2033 (USD Billion)
- 9.6 North America Breast Cancer Mammography Screening Market, by Product, 2024 – 2033
- 9.6.1 North America Breast Cancer Mammography Screening Market, by Product, 2024 – 2033 (USD Billion)
- 9.7 North America Breast Cancer Mammography Screening Market, by End User, 2024 – 2033
- 9.7.1 North America Breast Cancer Mammography Screening Market, by End User, 2024 – 2033 (USD Billion)
- 9.8. Europe
- 9.8.1 Europe Breast Cancer Mammography Screening Market, 2024 – 2033 (USD Billion)
- 9.8.1.1 Europe Breast Cancer Mammography Screening Market, by Country, 2024 – 2033 (USD Billion)
- 9.8.1 Europe Breast Cancer Mammography Screening Market, 2024 – 2033 (USD Billion)
- 9.9 Europe Breast Cancer Mammography Screening Market, by Type, 2024 – 2033
- 9.9.1 Europe Breast Cancer Mammography Screening Market, by Type, 2024 – 2033 (USD Billion)
- 9.10 Europe Breast Cancer Mammography Screening Market, by Technology, 2024 – 2033
- 9.10.1 Europe Breast Cancer Mammography Screening Market, by Technology, 2024 – 2033 (USD Billion)
- 9.11 Europe Breast Cancer Mammography Screening Market, by Product, 2024 – 2033
- 9.11.1 Europe Breast Cancer Mammography Screening Market, by Product, 2024 – 2033 (USD Billion)
- 9.12 Europe Breast Cancer Mammography Screening Market, by End User, 2024 – 2033
- 9.12.1 Europe Breast Cancer Mammography Screening Market, by End User, 2024 – 2033 (USD Billion)
- 9.13. Asia Pacific
- 9.13.1 Asia Pacific Breast Cancer Mammography Screening Market, 2024 – 2033 (USD Billion)
- 9.13.1.1 Asia Pacific Breast Cancer Mammography Screening Market, by Country, 2024 – 2033 (USD Billion)
- 9.13.1 Asia Pacific Breast Cancer Mammography Screening Market, 2024 – 2033 (USD Billion)
- 9.14 Asia Pacific Breast Cancer Mammography Screening Market, by Type, 2024 – 2033
- 9.14.1 Asia Pacific Breast Cancer Mammography Screening Market, by Type, 2024 – 2033 (USD Billion)
- 9.15 Asia Pacific Breast Cancer Mammography Screening Market, by Technology, 2024 – 2033
- 9.15.1 Asia Pacific Breast Cancer Mammography Screening Market, by Technology, 2024 – 2033 (USD Billion)
- 9.16 Asia Pacific Breast Cancer Mammography Screening Market, by Product, 2024 – 2033
- 9.16.1 Asia Pacific Breast Cancer Mammography Screening Market, by Product, 2024 – 2033 (USD Billion)
- 9.17 Asia Pacific Breast Cancer Mammography Screening Market, by End User, 2024 – 2033
- 9.17.1 Asia Pacific Breast Cancer Mammography Screening Market, by End User, 2024 – 2033 (USD Billion)
- 9.18. Latin America
- 9.18.1 Latin America Breast Cancer Mammography Screening Market, 2024 – 2033 (USD Billion)
- 9.18.1.1 Latin America Breast Cancer Mammography Screening Market, by Country, 2024 – 2033 (USD Billion)
- 9.18.1 Latin America Breast Cancer Mammography Screening Market, 2024 – 2033 (USD Billion)
- 9.19 Latin America Breast Cancer Mammography Screening Market, by Type, 2024 – 2033
- 9.19.1 Latin America Breast Cancer Mammography Screening Market, by Type, 2024 – 2033 (USD Billion)
- 9.20 Latin America Breast Cancer Mammography Screening Market, by Technology, 2024 – 2033
- 9.20.1 Latin America Breast Cancer Mammography Screening Market, by Technology, 2024 – 2033 (USD Billion)
- 9.21 Latin America Breast Cancer Mammography Screening Market, by Product, 2024 – 2033
- 9.21.1 Latin America Breast Cancer Mammography Screening Market, by Product, 2024 – 2033 (USD Billion)
- 9.22 Latin America Breast Cancer Mammography Screening Market, by End User, 2024 – 2033
- 9.22.1 Latin America Breast Cancer Mammography Screening Market, by End User, 2024 – 2033 (USD Billion)
- 9.23. The Middle-East and Africa
- 9.23.1 The Middle-East and Africa Breast Cancer Mammography Screening Market, 2024 – 2033 (USD Billion)
- 9.23.1.1 The Middle-East and Africa Breast Cancer Mammography Screening Market, by Country, 2024 – 2033 (USD Billion)
- 9.23.1 The Middle-East and Africa Breast Cancer Mammography Screening Market, 2024 – 2033 (USD Billion)
- 9.24 The Middle-East and Africa Breast Cancer Mammography Screening Market, by Type, 2024 – 2033
- 9.24.1 The Middle-East and Africa Breast Cancer Mammography Screening Market, by Type, 2024 – 2033 (USD Billion)
- 9.25 The Middle-East and Africa Breast Cancer Mammography Screening Market, by Technology, 2024 – 2033
- 9.25.1 The Middle-East and Africa Breast Cancer Mammography Screening Market, by Technology, 2024 – 2033 (USD Billion)
- 9.26 The Middle-East and Africa Breast Cancer Mammography Screening Market, by Product, 2024 – 2033
- 9.26.1 The Middle-East and Africa Breast Cancer Mammography Screening Market, by Product, 2024 – 2033 (USD Billion)
- 9.27 The Middle-East and Africa Breast Cancer Mammography Screening Market, by End User, 2024 – 2033
- 9.27.1 The Middle-East and Africa Breast Cancer Mammography Screening Market, by End User, 2024 – 2033 (USD Billion)
- Chapter 10. Company Profiles
- 10.1 Hologic Inc.
- 10.1.1 Overview
- 10.1.2 Financials
- 10.1.3 Product Portfolio
- 10.1.4 Business Strategy
- 10.1.5 Recent Developments
- 10.2 Siemens Healthineers AG
- 10.2.1 Overview
- 10.2.2 Financials
- 10.2.3 Product Portfolio
- 10.2.4 Business Strategy
- 10.2.5 Recent Developments
- 10.3 General Electric Company
- 10.3.1 Overview
- 10.3.2 Financials
- 10.3.3 Product Portfolio
- 10.3.4 Business Strategy
- 10.3.5 Recent Developments
- 10.4 Fujifilm Holdings Corporation
- 10.4.1 Overview
- 10.4.2 Financials
- 10.4.3 Product Portfolio
- 10.4.4 Business Strategy
- 10.4.5 Recent Developments
- 10.5 Koninklijke Philips N.V.
- 10.5.1 Overview
- 10.5.2 Financials
- 10.5.3 Product Portfolio
- 10.5.4 Business Strategy
- 10.5.5 Recent Developments
- 10.6 Canon Inc.
- 10.6.1 Overview
- 10.6.2 Financials
- 10.6.3 Product Portfolio
- 10.6.4 Business Strategy
- 10.6.5 Recent Developments
- 10.7 Planmed Oy
- 10.7.1 Overview
- 10.7.2 Financials
- 10.7.3 Product Portfolio
- 10.7.4 Business Strategy
- 10.7.5 Recent Developments
- 10.8 Carestream Health Inc.
- 10.8.1 Overview
- 10.8.2 Financials
- 10.8.3 Product Portfolio
- 10.8.4 Business Strategy
- 10.8.5 Recent Developments
- 10.9 Hitachi Ltd.
- 10.9.1 Overview
- 10.9.2 Financials
- 10.9.3 Product Portfolio
- 10.9.4 Business Strategy
- 10.9.5 Recent Developments
- 10.10 Agfa-Gevaert Group
- 10.10.1 Overview
- 10.10.2 Financials
- 10.10.3 Product Portfolio
- 10.10.4 Business Strategy
- 10.10.5 Recent Developments
- 10.11 Dilon Technologies Inc.
- 10.11.1 Overview
- 10.11.2 Financials
- 10.11.3 Product Portfolio
- 10.11.4 Business Strategy
- 10.11.5 Recent Developments
- 10.12 Internazionale Medico Scientifica S.r.l.
- 10.12.1 Overview
- 10.12.2 Financials
- 10.12.3 Product Portfolio
- 10.12.4 Business Strategy
- 10.12.5 Recent Developments
- 10.13 Metaltronica S.p.A.
- 10.13.1 Overview
- 10.13.2 Financials
- 10.13.3 Product Portfolio
- 10.13.4 Business Strategy
- 10.13.5 Recent Developments
- 10.14 FUJIFILM Sonosite Inc.
- 10.14.1 Overview
- 10.14.2 Financials
- 10.14.3 Product Portfolio
- 10.14.4 Business Strategy
- 10.14.5 Recent Developments
- 10.15 Delphinus Medical Technologies Inc.
- 10.15.1 Overview
- 10.15.2 Financials
- 10.15.3 Product Portfolio
- 10.15.4 Business Strategy
- 10.15.5 Recent Developments
- 10.16 Others.
- 10.16.1 Overview
- 10.16.2 Financials
- 10.16.3 Product Portfolio
- 10.16.4 Business Strategy
- 10.16.5 Recent Developments
- 10.1 Hologic Inc.
List Of Figure
Figures No 1 to 33
List Of Tables
Tables No 1 to 102
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2032
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
| Perspective | Primary research | Secondary research |
| Supply-side |
|
|
| Demand-side |
|
|
Market Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|
|
Prominent Player
- Hologic Inc.
- Siemens Healthineers AG
- General Electric Company
- Fujifilm Holdings Corporation
- Koninklijke Philips N.V.
- Canon Inc.
- Planmed Oy
- Carestream Health Inc.
- Hitachi Ltd.
- Agfa-Gevaert Group
- Dilon Technologies Inc.
- Internazionale Medico Scientifica S.r.l.
- Metaltronica S.p.A.
- FUJIFILM Sonosite Inc.
- Delphinus Medical Technologies Inc.
- Others
FAQs
The key factors driving the Market are Technological Advancements, Increasing Breast Cancer Incidence, Government Initiatives and Awareness Campaigns, Growing Healthcare Infrastructure And Personalized Screening Protocols.
The “Screening Mammography” category dominated the market in 2023.
The key players in the market are Hologic Inc., Siemens Healthineers AG, General Electric Company, Fujifilm Holdings Corporation, Koninklijke Philips N.V., Canon Inc., Planmed Oy, Carestream Health Inc., Hitachi Ltd., Agfa-Gevaert Group, Dilon Technologies Inc., Internazionale Medico Scientifica S.r.l., Metaltronica S.p.A., FUJIFILM Sonosite Inc., Delphinus Medical Technologies Inc., Others.
“Europe” had the largest share in the Breast Cancer Mammography Screening Market.
The global market is projected to grow at a CAGR of 8.6% during the forecast period, 2024-2033.
The Breast Cancer Mammography Screening Market size was valued at USD 4.1 Billion in 2024.